Do you want to invest in Veriphi's PledgeMe investment round?

Veriphi is an exciting Medtech company that aims to globally transform intravenous medication delivery, the most common, high-risk patient intervention in hospitals. One million hospital patients are harmed every year by preventable medication error in the United States alone. 

Over the last 15 years, we have developed a groundbreaking spectral analyser that uses lasers, artificial intelligence and cloud computing to verify drug identity and concentration to ensure that intravenous drug administration is safe and accurate. The analyser, and the know-how gained, is a technological breakthrough recognised by 22 granted global patents, including eight granted US patents.

We recently signed our first commercial supply agreement with a leading Australian healthcare provider.

We are aiming to raise $2 million from the public through the PledgeMe platform to help drive initial sales into the Australian market as well as begin to explore opportunities in the US.

Register your interest in our PledgeMe investment round below and we'll add you to our investor newsletter.